Short Courses and Special Courses

SC29 - Practical Issues and Clinical Implications in Urinary Bladder Pathology

Wednesday, March 21, 2018 - 1:30 pm - 5:30 pm
This Short Course session includes up to a one-hour break.

Session Credits:

3 CME and 3 SAMs

Faculty

Qihui “Jim” Zhai, MD, Mayo Clinic Jacksonville, FL
Jae Ro, MD, PhD, Houston Methodist Hospital, Houston, TX

Course Description

Two seasoned pathologists will provide insights on handling practical issues and their clinical relevance commonly encountered in diagnosing urinary bladder tumors. An analytic diagnostic approach will be utilized to address overlapping and distinctive histologic features as well as the usage of ancillary tools among these diagnostic dilemmas. Related material will be updated based on the 2016 WHO Classifications. Appropriate language for conveying key pathologic findings, particularly for equivocal and challenging scenarios, will be illustrated. A case-based and interactive approach between the presenters and attendees will be utilized. This course is designed for pathologists in training, practicing general surgical pathologists in community hospitals, and GU pathologists in academic medical centers.

Learning Objective

Upon completion of this educational activity, the learner will be able to:

  • Illustrate the normal histology of urinary bladder and related potential microscopic staging pitfalls namely the depth of invasion
  • Discuss diagnostic issues in flat urothelial lesions, i.e. how to separate reactive processes from dysplasia and carcinoma in situ
  • Classify papillary urothelial lesions, differentiate between papilloma, PUNLMP, low grade and high-grade papillary urothelial carcinoma
  • Illustrate the morphologic features of several variants of invasive urothelial carcinoma and discuss their related clinical significance

 

Continuing Medical Education and Maintenance of Certification

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this live activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Physicians must take and pass the post-test in order to claim SAMs credit.

Physicians can earn a maximum of 3 SAM credit hours.

 

Return to 2018 Annual Meeting Short Course Page

Meetings

view more